已阅读5页,还剩23页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Hypertension In Chronic Kidney Disease,Renal disease,loss of nephrons,Systemic hypertension,Proteinuria,Progressive decline in GFR,Introduction,RENAL INJURY,Nephron mass Glomerular capillary hypertension Glomerular permeability to macromolecules Filtration of plasma proteins Proteinuria Excessive tubular protein reabsorbtion Tubulo-interstitial inflammation,RENAL SCARRING,SYSTEMIC HYPERTENSION,CKD: Common pathway in disease progression,Therapeutic intervention inhibiting this common pathway may succeed in slowing the rate of progression of CRF irrespective of the initiating cause,CKD: Common pathway in disease progression,Relative risk of ESRD according to quintile BP,MRFIT study N= 332,544 men,How important is systemic blood pressure control?,Treatment goal for hypertension in the general population has remained relatively the same for the last decade.,What should be the treatment goal?,Should be lower than the general population Should be tailored according to :,What should be the treatment goal for renal disease?,the severity of renal failure the severity of the proteinuria,Aggressive BP control to 125/75 mmHg showed better preservation of GFR for those with proteinuria 3g/day. No additional benefit if proteinuria is 1g/day,Klahr S, Levey AS: NEJM 1994; 330:877,Proteinuria and target BP control,What should be the treatment goal for renal disease?,Treatment goal should depend on the severity of proteinuria,What should be the treatment goal for non diabetic renal disease?,There is indisputable evidence from animal, laboratory and clinical studies that proteinuria per se contributes to progressive renal injury,Proteinuria,Proteinuria and renal disease progression,Klahr S, Levey AS: NEJM 1994; 330:877,Proteinuria and renal disease progression,REIN SUBSTUDY : Progression of renal disease according to severity of proteinuria,It is now clear that different classes of antihypertensive agents have different antiproteinuric capacity ACEI and ARB have been showed to exhibit the highest capacity to diminish protein excretion in urine,Proteinuria and renal disease progression,REIN Study : KIDNEY SURVIVAL,ACE Inhibitors In Nephropathy,P=0.04,REIN Study,ACE Inhibitors In Nephropathy,COOPERATE STUDY: Median urinary protein excretion,ACEI, ARB and combination treatment in Nephropathy,ACEI, ARB and combination treatment in Nephropathy,COOPERATE STUDY: proportion reaching endpoints,ACEI or ARB should be the first choice antihypertensive agent in patient with significant proteinuria.,Choice of antihypertensive agent for non diabetic renal disease,Dose of ACEI or ARB should be titrated to achieve both target BP and the disappearance of proteinuria,Choice of antihypertensive agent for non diabetic renal disease,If target blood pressure is not achieved and especially in the presence of persistent proteinuria, an ARB should be added.,Choice of antihypertensive agent for non diabetic renal disease,Check Cr and K+ within 7-14 days after starting treatment especially in the presence of renal impairment An acute rise in Cr of 30% should be tolerated if BP is adequately reduced (140/90), hyperkalaemia is absent and the patient is euvolaemic If Cr continues to rise, or hyperkalaemia persist, stop drugs; assess for bilateral RAS,Precautions when starting ACEI or ARB,Choice of combination antihypertensive agents depend on the existing comorbidity,Choice of antihypertensive agent for non diabetic renal disease,Drug(s) for the compelling indication,Choice of Anti-Hypertensive drugs in patient with concomitant disease,Since studies have demonstrated that most hypertensive patients will require multiple drugs to achieve target BP, the argument about which one is superior has become almost irrelevant We must provide all of the drugs ne
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 建筑安全施工人员培训
- 2024年个人简历的自我鉴定模板集锦9篇
- 2024年中专毕业生实习后的自我鉴定
- 2024年一个中国孩子的呼声教案模板八篇
- 2024年上学期教学工作总结汇编10篇
- 2024年个人理财学习心得体会
- 摩托车零部件供应链的管理与控制
- 湖北省黄石市有色中学2023-2024学年九年级下学期收心考试语文试卷
- 员工警告通知书
- 监理拟投入本工程的监理设施
- 女生青春期性教育课件
- 2023年广东广州中考化学试卷附答案解析
- 《酒店管理概论》考试复习题库(含答案)
- 2022年监理工程师考试题库自测300题附答案(安徽省专用)
- 幼儿园大班数学10以内数自编应用题练习-课件
- 工商企业管理毕业论文5000字(5篇)
- 急性上消化道出血诊治专家共识演示文稿
- 学习通-尔雅教育《人工智能》答案
- 夸夸我的班主任800字(9篇)
- 健康中国行动宣传手册课件
- 污水处理室巡检表
评论
0/150
提交评论